Novartis CEO reportedly weighing U.S. price cuts as Trump’s MFN deadline nears

 

• Vasant Narasimhan stated that Novartis is "working to eliminate the price gap between the US and other industrialized countries" to reduce drug prices for Americans.
• He emphasized that the company is collaborating with the government to help Americans pay less for medicines.
• Narasimhan acknowledged that American patients currently bear much of the cost for innovations, indicating other countries must contribute more.
• He noted that establishing local manufacturing for the American market would likely take three to four years.

https://ground.news/article/novartis-chief-eyes-ways-to-end-higher-us-drug-prices-media